STEAP2-AS1: A Potential Drug Target and Biomarker (G100874100)

Target Name: STEAP2-AS1

NCBI ID: G100874100

STEAP2-AS1

Other Name(s): STEAP2 antisense RNA 1

STEAP2-AS1: A Potential Drug Target and Biomarker

Steep2-AS1, also known as ST2P2, is a protein that is expressed in various tissues, including the brain, heart, and kidneys. It is a member of the Steen family of proteins, which are known for their role in intracellular signaling pathways. The protein encoded by the STEAP2 gene has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival.

Recent studies have suggested that STEAP2-AS1 may be a drug target in the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target is due to its unique structure, which allows for the development of small molecules that can interact with it and modulate its activity.

One of the key features of STEAP2-AS1 is its transmembrane domain. This region of the protein spans the entire cell membrane and is involved in the regulation of various cellular processes. The transmembrane domain is known for its ability to interact with various signaling molecules, including tyrosine and estrogen.

This interaction between STEAP2-AS1 and signaling molecules has led to the hypothesis that it may be a drug target for diseases that are characterized by the overproduction or dysfunction of these molecules. For example, increased levels of tyrosine and estrogen have been linked to the development of various cancers, and disruptions in their regulation have been implicated in the development of neurodegenerative diseases.

Another potential mechanism by which STEAP2-AS1 may be a drug target is its role in the regulation of cellular adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and it is a critical factor in the development and maintenance of tissues. Disruptions in cellular adhesion have been implicated in the development of various diseases, including cancer, and the regulation of these processes is critical for the development and maintenance of a healthy tissue microenvironment.

In addition to its role in cellular adhesion, STEAP2-AS1 has also been shown to play a role in the regulation of cellular migration. Migration is the process by which cells move from one location to another, and it is critical for the development and maintenance of tissues and organs. The regulation of cellular migration is critical for the development and maintenance of tissues and organs, and disruptions in this process have been implicated in the development of various diseases, including cancer.

The potential drug targets for STEAP2-AS1 are vast, and its role in the regulation of cellular processes makes it an attractive target for the development of new treatments for a variety of diseases. As research continues to advance, the full potential of STEAP2-AS1 as a drug target will become increasingly clear.

Protein Name: STEAP2 Antisense RNA 1

The "STEAP2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STEAP2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets